C07D 263/58
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
C07D263/58 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 793 US grants and 671 published applications in this corpus.
Search patents in C07D- Granted patents
- 793
- Published applications
- 671
- Assignees
- 424
- Inventors
- 2,605
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 9 | 0 |
| 1978 | 12 | 0 |
| 1979 | 5 | 0 |
| 1980 | 6 | 0 |
| 1981 | 8 | 0 |
| 1982 | 13 | 0 |
| 1983 | 10 | 0 |
| 1984 | 20 | 0 |
| 1985 | 13 | 0 |
| 1986 | 10 | 0 |
| 1987 | 18 | 0 |
| 1988 | 11 | 0 |
| 1989 | 16 | 0 |
| 1990 | 13 | 0 |
| 1991 | 7 | 0 |
| 1992 | 9 | 0 |
| 1993 | 13 | 0 |
| 1994 | 17 | 0 |
| 1995 | 15 | 0 |
| 1996 | 14 | 0 |
| 1997 | 10 | 0 |
| 1998 | 11 | 0 |
| 1999 | 8 | 0 |
| 2000 | 13 | 0 |
| 2001 | 22 | 7 |
| 2002 | 30 | 24 |
| 2003 | 23 | 36 |
| 2004 | 22 | 49 |
| 2005 | 19 | 37 |
| 2006 | 19 | 43 |
| 2007 | 25 | 33 |
| 2008 | 21 | 29 |
| 2009 | 24 | 35 |
| 2010 | 29 | 40 |
| 2011 | 19 | 35 |
| 2012 | 19 | 29 |
| 2013 | 27 | 19 |
| 2014 | 28 | 28 |
| 2015 | 26 | 27 |
| 2016 | 18 | 27 |
| 2017 | 24 | 23 |
| 2018 | 14 | 17 |
| 2019 | 24 | 25 |
| 2020 | 20 | 20 |
| 2021 | 9 | 12 |
| 2022 | 11 | 11 |
| 2023 | 11 | 21 |
| 2024 | 6 | 20 |
| 2025 | 8 | 11 |
| 2026 | 10 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Linear dipeptidyl peptidase 1 inhibitors and uses thereof14 Jul 2026US 12,679,815 B2Insmed Incorporated
- Compounds19 May 2026US 12,630,516 B2NRG Therapeutics Ltd
- Small molecule GRB2 stabilizers for Ras map kinase inhibition14 Apr 2026US 12,599,583 B2Board of Regents, The University of Texas System
- Linear dipeptidyl peptidase 1 inhibitors and uses thereof24 Sep 2026US 2026/0285821 A1
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
- 3-alkylamine indole activators of serotonin receptors10 Sep 2026US 2026/0265250 A1
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
- Substituted Hydroxystilbene Compounds and Derivatives, Synthesis and Uses Thereof23 Jul 2026US 2026/0209152 A1Kynan Duke IP, LLC
Most cited
By later US patents
- Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic compounds having neuroleptic activity127US 4,831,031 APfizer Inc. · 1989
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997
- Location determination method and system for asset tracking devices100US 7,315,281 B2G2 Microsystems Pty. Ltd. · 2008
- Photographic element and process comprising a compound which comprises two timing groups in sequence90US 4,861,701 AEastman Kodak Company · 1989